Bioactive VEGF-C from E. coli
Authors:
Open Access
- 28 October 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-16
Abstract
Vascular endothelial growth factor-C (VEGF-C) stimulates lymphatic vessel growth in transgenic models, via viral gene delivery, and as a recombinant protein. Expressing eukaryotic proteins like VEGF-C in bacterial cells has limitations, as these cells lack specific posttranslational modifications and provisions for disulfide bond formation. However, given the cost and time savings associated with bacterial expression systems, there is considerable value in expressing VEGF-C using bacterial cells. We identified two approaches that result in biologically active Escherichia coli-derived VEGF-C. Expectedly, VEGF-C expressed from a truncated cDNA became bioactive after in vitro folding from inclusion bodies. Given that VEGF-C is one of the cysteine-richest growth factors in humans, it was unclear whether known methods to facilitate correct cysteine bond formation allow for the direct expression of bioactive VEGF-C in the cytoplasm. By fusing VEGF-C to maltose-binding protein and expressing these fusions in the redox-modified cytoplasm of the Origami (DE3) strain, we could recover biological activity for deletion mutants lacking the propeptides of VEGF-C. This is the first report of a bioactive VEGF growth factor obtained from E. coli cells circumventing in-vitro folding.Keywords
All Related Versions
Funding Information
- Päivikki ja Sakari Sohlbergin Säätiö
- Jane ja Aatos Erkon Säätiö
- Novo Nordisk Fonden (21036)
- Research Council of Finland (337430, 337120)
- Paulon Säätiö
- Einar and Karin Stroem Foundation for Medical Research
This publication has 68 references indexed in Scilit:
- Production of Soluble Human Vascular Endothelial Growth Factor VEGF-A165-Heparin Binding Domain in Escherichia coliPLOS ONE, 2013
- An engineered eukaryotic protein glycosylation pathway in Escherichia coliNature Chemical Biology, 2012
- Pre-expression of a sulfhydryl oxidase significantly increases the yields of eukaryotic disulfide bond containing proteins expressed in the cytoplasm of E.coliMicrobial Cell Factories, 2011
- αB-crystallin regulation of angiogenesis by modulation of VEGFBlood, 2010
- Structural determinants of growth factor binding and specificity by VEGF receptor 2Proceedings of the National Academy of Sciences, 2010
- Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coliMicrobial Cell Factories, 2009
- Redox compartmentalization in eukaryotic cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Crystal Structure of Human Vascular Endothelial Growth Factor-B: Identification of Amino Acids Important for Receptor BindingJournal of Molecular Biology, 2006
- Expression of Biologically Active Isoforms of the Tumor Angiogenesis Factor VEGF inEscherichia coliBiochemical and Biophysical Research Communications, 1996
- Secretion of active kringle-2-serine protease in Escherichia coliBiochemistry, 1990